The history of copyright's flagship drug presents a interesting case for stakeholders in the medicinal sector. While initially a phenomenal success, generating billions, the patent expiration and the subsequent flood https://knockoff747563.onesmablog.com/the-little-copyright-and-pharma-a-risky-bet-83206524